References
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. https://doi.org/10.3322/canjclin.55.2.74
- Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24:971-983. https://doi.org/10.1038/nbt1235
- Kim VN. Small RNAs: classification, biogenesis, and function. Mol Cells 2005;19:1-15. https://doi.org/10.1016/j.molcel.2005.05.026
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297. https://doi.org/10.1016/S0092-8674(04)00045-5
- Bushati N, Cohen SM. MicroRNA functions. Annu Rev Cell Dev Biol 2007;23:175-205. https://doi.org/10.1146/annurev.cellbio.23.090506.123406
- Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009;27:5848-5856. https://doi.org/10.1200/JCO.2009.24.0317
- Meola N, Gennarino VA, Banfi S. MicroRNAs and genetic diseases. Pathogenetics 2009;2:7. https://doi.org/10.1186/1755-8417-2-7
- Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, et al. E2F1-regulated microRNAs impair TGFbetadependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008;13:272-286. https://doi.org/10.1016/j.ccr.2008.02.013
- Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-658. https://doi.org/10.1053/j.gastro.2007.05.022
- Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010;70:3119-3127. https://doi.org/10.1158/0008-5472.CAN-09-4250
- Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG, et al. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 2009;28:3360- 3370. https://doi.org/10.1038/onc.2009.192
- Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, et al. miR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One 2009;4:e8445. https://doi.org/10.1371/journal.pone.0008445
- Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-2261. https://doi.org/10.1073/pnas.0510565103
- Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282:14328-14336. https://doi.org/10.1074/jbc.M611393200
- Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 2008;105:7004-7009. https://doi.org/10.1073/pnas.0801615105
- Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009;273:233-242. https://doi.org/10.1016/j.canlet.2008.08.003
- Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, Jing Y, et al. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 2010;101:2241-2247. https://doi.org/10.1111/j.1349-7006.2010.01667.x
- Nikolic Z, Savic Pavicevic D, Vucic N, Cidilko S, Filipovic N, Cerovic S, et al. Assessment of association between genetic variants in microRNA genes hsa-miR-499, hsa-miR-196a2 and hsa-miR-27a and prostate cancer risk in Serbian population. Exp Mol Pathol 2015;99:145-150. https://doi.org/10.1016/j.yexmp.2015.06.009
- Shi D, Li P, Ma L, Zhong D, Chu H, Yan F, et al. A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One 2012;7:e46566. https://doi.org/10.1371/journal.pone.0046566
- Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A 2007;104: 16170-16175. https://doi.org/10.1073/pnas.0703942104
- Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010;285:17869-17879. https://doi.org/10.1074/jbc.M110.101055
- Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-10518. https://doi.org/10.1073/pnas.0804549105
- El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004;50:564-573. https://doi.org/10.1373/clinchem.2003.028506
- Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18: 997-1006. https://doi.org/10.1038/cr.2008.282
- Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008;54:482-490. https://doi.org/10.1373/clinchem.2007.097972
- Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008;3:e3148. https://doi.org/10.1371/journal.pone.0003148
- Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010;102:1174-1179. https://doi.org/10.1038/sj.bjc.6605608
- Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010;16:360-364. https://doi.org/10.1111/j.1601-0825.2009.01646.x
- Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-126. https://doi.org/10.1002/ijc.25007
- Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 2009;14: 529-538. https://doi.org/10.3109/13547500903150771
- Wang Y, Lee CG. MicroRNA and cancer: focus on apoptosis. J Cell Mol Med 2009;13:12-23.
- Ferracin M, Lupini L, Salamon I, Saccenti E, Zanzi MV, Rocchi A, et al. Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget 2015;6:14545-14555. https://doi.org/10.18632/oncotarget.3859
- Du M, Shi D, Yuan L, Li P, Chu H, Qin C, et al. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep 2015;5:10437. https://doi.org/10.1038/srep10437
- Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011;39:7223-7233. https://doi.org/10.1093/nar/gkr254
- Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-433. https://doi.org/10.1038/ncb2210
- Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011;47:784-791. https://doi.org/10.1016/j.ejca.2010.10.025
- Ma Y, Yu S, Zhao W, Lu Z, Chen J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 2010;298:150-158. https://doi.org/10.1016/j.canlet.2010.06.012
- Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, Akbari Moqadam F, et al. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 2011;10:2172-2183. https://doi.org/10.4161/cc.10.13.16248
Cited by
- Protective mechanisms of microRNA-27a against oxygen-glucose deprivation-induced injuries in hippocampal neurons vol.11, pp.8, 2016, https://doi.org/10.4103/1673-5374.189194
- Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients vol.57, pp.3, 2017, https://doi.org/10.1007/s12020-016-1150-z
- The Diverse Roles of microRNAs at the Host–Virus Interface vol.10, pp.8, 2018, https://doi.org/10.3390/v10080440
- MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives vol.24, pp.30, 2018, https://doi.org/10.3748/wjg.v24.i30.3313